Alzheon

0 followers


Alzheon is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.

Industries

Employees

11-50

Links


Org chart

Martin Tolar
Founder, President & CEO
Collapse
Kenneth Mace
Chief Financial Officer
Aidan Power
Chief Development Officer
Adem Albayrak
Chief Data Officer
Earvin Liang
VP, Clinical Development
Patrick Kesslak
VP, Clinical Development & Medical Affairs
Susan Flint
VP, Clinical Operations
Yasemin Khakian
Chief Of Staff

Board & advisors

Neil Flanzraich
Executive Chairman
Christopher Noel Dunn
Non Executive Director
Carmela R. Abraham
Scientific Advisor
Kaj Blennow
Scientific Advisor
Keith Crutcher
Scientific Advisor
Serge Gauthier
Scientific Advisor
Jakub Hort
Scientific Advisor
Cyril Höschl
Scientific Advisor
Steven Jacobsen
Scientific Advisor
Louis Kirby
Scientific Advisor
Miia Kivipelto
Scientific Advisor
William Mobley
Scientific Advisor
Anton Porsteinsson
Scientific Advisor
Eric Reiman
Scientific Advisor
Marwan N. Sabbagh
Scientific Advisor
Carl Sadowsky
Scientific Advisor
John Sampalis
Scientific Advisor
Pete Snyder
Scientific Advisor
Bruno Vellas
Scientific Advisor
Murali Doraiswamy
Scientific Advisor
Katerina Sheardova
Scientific Advisor
Ara S. Khachaturian
Scientific Advisor
Michael W. Weiner
Scientific Advisor